VISTIDE Side Effects

6436723-2 | Iritis, Renal Failure Acute
on Nov 04, 2009 Male patient from UNITED STATES , weighting 178.6 lb, was diagnosed with cytomegalovirus test positive, hiv infection (What is hiv infection?) and was treated with Vistide (View Usage). Patient experienced the following unwanted or unexpected effects: iritis, renal failure acute. Vistide dosage: . During the same period patient was treated with ATRIPLA (View Atripla Review and Atripla Label ). Patient was hospitalized and became disabled.

6348170-2 | Abnormal Behaviour, Hemiparesis, Sleep Disorder, Somnolence
Patient was taking Vistide (View Usage). Patient had the following side effects: abnormal behaviour, hemiparesis, sleep disorder (What is sleep disorder?), somnolence on Aug 31, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 28.66 lb, was diagnosed with herpes virus infection, herpes simplex (What is herpes simplex?), staphylococcal infection (What is staphylococcal infection?), vitamin supplementation, prophylaxis, anaemia, selenium deficiency, skin lesion and. Vistide dosage: . During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), ERGOCALCIFEROL (View Ergocalciferol Review and Ergocalciferol Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), PREDNISOLONE ACETATE (View Prednisolone Acetate Review and Prednisolone Acetate Label ), SELENIUM (View Selenium Review and Selenium Label ), TRIFLURIDINE (View Trifluridine Review and Trifluridine Label ). Patient was hospitalized and became disabled.

6340164-6 | Herpes Zoster, Pneumonia
Adverse event was reported on Aug 25, 2009 by a Male patient taking Vistide (View Usage) (Dosage: ) was diagnosed with papilloma viral infection and. Location: UNITED STATES , 39 years of age, weighting 216.1 lb, After Vistide was administered, patient had the following side effects: herpes zoster, pneumonia (What is pneumonia?). Patient was hospitalized.

6331450-4 | Pulmonary Oedema, Respiratory Failure
on Aug 18, 2009 Male patient from AUSTRALIA , child 7. years of age, was treated with Vistide (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary oedema, respiratory failure. Vistide dosage: .


6329573-9 | Nephropathy Toxic
on Jan 07, 2009 Male patient from UNITED STATES , child 6 years of age, was diagnosed with cytomegalovirus chorioretinitis and was treated with Vistide (View Usage). Patient had the following side effects: nephropathy toxic. Vistide dosage: . Patient was hospitalized.

6329571-5 | Nephropathy Toxic
Patient was taking Vistide (View Usage). After Vistide was administered, patient had the following side effects: nephropathy toxic on Jan 07, 2009 from UNITED STATES Additional patient health information: Female patient , 37 years of age, was diagnosed with cytomegalovirus chorioretinitis and. Vistide dosage: 2 Mg/kg, 1 In 1 Wk 5 Mg/kg, 1 In 1 Wk 1 Mg/kg, 1 In 1 Wk.

6124988-6 | Squamous Cell Carcinoma
Adverse event was reported on Mar 10, 2009 by a Female patient taking Vistide (View Usage) (Dosage: ) . Location: UNITED STATES , 14 years of age, Patient experienced the following unwanted or unexpected effects: squamous cell carcinoma.

6084571-8 | Squamous Cell Carcinoma
on Feb 09, 2009 Male patient from UNITED STATES , 53 years of age, weighting 145.5 lb, was diagnosed with papilloma viral infection and was treated with Vistide (View Usage). Patient had the following side effects: squamous cell carcinoma. Vistide dosage: .

5899265-9 | Vulvitis
on Sep 17, 2008 Female patient from UNITED STATES , 25 years of age, weighting 211.6 lb, was diagnosed with papilloma viral infection, hiv infection (What is hiv infection?) and was treated with Vistide (View Usage). After Vistide was administered, patient had the following side effects: vulvitis. Vistide dosage: . During the same period patient was treated with A + D OINTMENT (View A + D Ointment Review and A + D Ointment Label ), TRUVADA (View Truvada Review and Truvada Label ), NORVIR (View Norvir Review and Norvir Label ), REYATAZ (View Reyataz Review and Reyataz Label ), YASMIN (View Yasmin Review and Yasmin Label ).

5886837-0 | Vulvitis
Patient was taking Vistide (View Usage). Patient experienced the following unwanted or unexpected effects: vulvitis on Sep 11, 2008 from UNITED STATES Additional patient health information: Female patient , 25 years of age, weighting 211.6 lb, was diagnosed with papilloma viral infection, hiv infection (What is hiv infection?) and. Vistide dosage: . During the same period patient was treated with A + D OINTMENT (View A + D Ointment Review and A + D Ointment Label ), TRUVADA (View Truvada Review and Truvada Label ), NORVIR (View Norvir Review and Norvir Label ), REYATAZ (View Reyataz Review and Reyataz Label ), YASMIN (View Yasmin Review and Yasmin Label ).

5751715-4 | Renal Failure
Adverse event was reported on May 14, 2008 by a Male patient taking Vistide (View Usage) (Dosage: ) was diagnosed with castleman's disease, hiv infection (What is hiv infection?), septic shock and. Location: UNITED STATES , 47 years of age, Patient had the following side effects: renal failure. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), KIVEXA (View Kivexa Review and Kivexa Label ), KALETRA (View Kaletra Review and Kaletra Label ), NEXIUM (View Nexium Review and Nexium Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

5732537-7 | Pulmonary Hypertension
on Apr 30, 2008 Male patient from UNITED STATES , 19 years of age, was diagnosed with adenovirus infection, pancytopenia, haemochromatosis and was treated with Vistide (View Usage). After Vistide was administered, patient had the following side effects: pulmonary hypertension (What is pulmonary hypertension?). Vistide dosage: . During the same period patient was treated with NOXAFIL (View Noxafil Review and Noxafil Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), DESFERAL (View Desferal Review and Desferal Label ). Patient was hospitalized.

5732131-8 | Renal Failure
on Apr 30, 2008 Male patient from UNITED STATES , 47 years of age, was diagnosed with castleman's disease, hiv infection (What is hiv infection?), septic shock and was treated with Vistide (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure. Vistide dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ), KIVEXA (View Kivexa Review and Kivexa Label ), KALETRA (View Kaletra Review and Kaletra Label ), NEXIUM (View Nexium Review and Nexium Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

5589034-1 | Polydipsia, Renal Failure Acute
Patient was taking Vistide (View Usage). Patient had the following side effects: polydipsia, renal failure acute on Dec 27, 2007 from UNITED STATES Additional patient health information: Female patient , child 9 years of age, was diagnosed with laryngeal papilloma and. Vistide dosage: . During the same period patient was treated with PROBENECID (View Probenecid Review and Probenecid Label ), INTERFERON ALFA 2A (View Interferon Alfa-2a Review and Interferon Alfa-2a Label ).

5472144-7 | Hypokalaemia, Hypomagnesaemia, Proteinuria
Adverse event was reported on Sep 20, 2007 by a Male patient taking Vistide (View Usage) (Dosage: ) . Location: UNITED STATES , 45 years of age, After Vistide was administered, patient had the following side effects: hypokalaemia, hypomagnesaemia, proteinuria. During the same period patient was treated with PROBENECID (View Probenecid Review and Probenecid Label ). Patient was hospitalized.

5460879-1 | Renal Failure
on Sep 06, 2006 Male patient from UNITED STATES , 54 years of age, was diagnosed with cytomegalovirus chorioretinitis and was treated with Vistide (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure. Vistide dosage: . During the same period patient was treated with FUZEON (View Fuzeon Review and Fuzeon Label ).

5286303-X | Myeloid Leukaemia, Neutropenia, White Blood Cell Count Decreased
on Mar 22, 2007 Male patient from UNITED STATES , 33 years of age, was diagnosed with cytomegalovirus test and was treated with Vistide (View Usage). Patient had the following side effects: myeloid leukaemia, neutropenia, white blood cell count decreased. Vistide dosage: .

5278811-2 | Pulmonary Oedema, Respiratory Depression
Patient was taking Vistide (View Usage). After Vistide was administered, patient had the following side effects: pulmonary oedema, respiratory depression on Mar 20, 2007 from UNITED STATES Additional patient health information: Male patient , weighting 126.1 lb, was diagnosed with respiratory papilloma, pain (What is pain?), nausea (What is nausea?), prophylaxis and. Vistide dosage: . During the same period patient was treated with ULTIVA (View Ultiva Review and Ultiva Label ), PROPOFOL (View Propofol Review and Propofol Label ), ZOFRAN (View Zofran Review and Zofran Label ), KEFZOL (View Kefzol Review and Kefzol Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

5255232-X | Pulmonary Oedema, Respiratory Depression
Adverse event was reported on Feb 26, 2007 by a Male patient taking Vistide (View Usage) (Dosage: ) was diagnosed with respiratory papilloma, pain (What is pain?), nausea (What is nausea?), prophylaxis and. Location: UNITED STATES , weighting 126.1 lb, Patient experienced the following unwanted or unexpected effects: pulmonary oedema, respiratory depression. During the same period patient was treated with ULTIVA (View Ultiva Review and Ultiva Label ), PROPOFOL (View Propofol Review and Propofol Label ), ZOFRAN (View Zofran Review and Zofran Label ), KEFZOL (View Kefzol Review and Kefzol Label ), DECADRON (View Decadron Review and Decadron Label ). Patient was hospitalized.

5126282-9 | Blood Creatinine Increased, White Blood Cell Count Decreased
on Apr 17, 2006 Male patient from UNITED STATES , 17 years of age, weighting 126.8 lb, was diagnosed with adenovirus infection and was treated with Vistide (View Usage). Patient had the following side effects: blood creatinine increased, white blood cell count decreased. Vistide dosage: 1 Mg/kg, 1 In 1 Hr, Intravenous Drip. During the same period patient was treated with PROBENECID (PROBENECID) (1 G) (View Probenecid (probenecid) (1 G) Review and Probenecid (probenecid) (1 G) Label ), ANTIBIOTICS (ANTIBIOTICS) (View Antibiotics (antibiotics) Review and Antibiotics (antibiotics) Label ). Patient was hospitalized.

5126281-7 | Uveitis
on Jul 20, 2005 Male patient from UNITED STATES , 79 years of age, was diagnosed with lymphoma (What is lymphoma?) and was treated with Vistide (View Usage). After Vistide was administered, patient had the following side effects: uveitis. Vistide dosage: 1 In 1 Wk, Other. During the same period patient was treated with PROBENECID (View Probenecid Review and Probenecid Label ).

4855133-2 | Disease Recurrence, Human Herpesvirus 6 Infection, Laryngeal Dysplasia, Respiratory Papilloma
Patient was taking Vistide (View Usage). Patient experienced the following unwanted or unexpected effects: disease recurrence, human herpesvirus 6 infection, laryngeal dysplasia, respiratory papilloma on Dec 05, 2005 from UNITED STATES Additional patient health information: Female patient , 28 years of age, was diagnosed with disease recurrence, respiratory papilloma and. Vistide dosage: Intralesional.

4849339-6 | Laryngeal Dysplasia, Respiratory Papilloma
Adverse event was reported on Dec 05, 2005 by a Female patient taking Vistide (View Usage) (Dosage: ) was diagnosed with respiratory papilloma and. Location: UNITED STATES , 28 years of age, Patient had the following side effects: laryngeal dysplasia, respiratory papilloma.

4849283-4 | Dermatitis Bullous, Photosensitivity Reaction
on Nov 22, 2005 Male patient from UNITED STATES , 50 years of age, was diagnosed with ill-defined disorder and was treated with Vistide (View Usage). After Vistide was administered, patient had the following side effects: dermatitis bullous, photosensitivity reaction. Vistide dosage: Intravenous. Patient was hospitalized.

4842423-2 | Dermatitis Bullous, Photosensitivity Reaction
on Nov 22, 2005 Male patient from UNITED STATES , 50 years of age, was diagnosed with ill-defined disorder and was treated with Vistide (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis bullous, photosensitivity reaction. Vistide dosage: . Patient was hospitalized.

4641696-9 | Glomerulosclerosis, Haemodialysis, Pain, Renal Failure, Renal Interstitial Fibrosis, Renal Tubular Atrophy, Renal Tubular Necrosis, Vaginal Exfoliation
Patient was taking Vistide (View Usage). Patient had the following side effects: glomerulosclerosis, haemodialysis, pain (What is pain?), renal failure, renal interstitial fibrosis, renal tubular atrophy, renal tubular necrosis, vaginal exfoliation on Apr 05, 2005 from Additional patient health information: Female patient , 23 years of age, weighting 135.0 lb, was diagnosed with condyloma acuminatum and. Vistide dosage: See Image. During the same period patient was treated with IMURAN (View Imuran Review and Imuran Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized and became disabled.